Mixtard 30 NovoLet

insulin human premixed 30/70 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mixtard 30 NovoLet, covering 2016-12-13 to 2017-02-28. Get the full timeline:

Most recent: Clinical Trial Update: Observational Study With Mixtard® 30 NovoLet® to Assess Patient Satisfaction